{"doc_id": "si-2021-0586-reg-1", "parent_doc_id": "si-2021-0586", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 586 of 2021", "title": "the Health (Amendment) (No. 2) Act 2021 (No. 24 of 2021)) of the Health Act", "year": 2021, "heading": "1. (1) These Regulations may be cited as the Health Act 1947 (Sections", "text_raw": "1. (1) These Regulations may be cited as the Health Act 1947 (Sections \nindoor premises) \n\n31AB and 31AD) (Covid-19) (Operation of certain \n(Amendment) (No.8) Regulations 2021. \n\n(2) These Regulations shall come into operation on the 10th day of \n\nNovember 2021.", "text_norm": "1 (1) regulation may cited health act 1947 (sections indoor premises) 31ab 31ad) (covid-19) (operation certain (amendment) (no.8) regulation 2021 (2) regulation shall come operation 10th day november 2021", "start_char": 1110, "end_char": 1375, "source_path": "downloads\\2021\\2021_0586.pdf", "extraction_method": "pdfminer", "checksum": "sha256:2b49bf20f4fc1db37f539c4e692fdafbefe8a91a9fb1896b3cfd8bbcce9ce426", "cross_refs": []}
{"doc_id": "si-2021-0586-reg-2", "parent_doc_id": "si-2021-0586", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 586 of 2021", "title": "the Health (Amendment) (No. 2) Act 2021 (No. 24 of 2021)) of the Health Act", "year": 2021, "heading": "2. The Health Act 1947 (Sections 31AB and 31AD) (Covid-19)", "text_raw": "2. The Health Act 1947 (Sections 31AB and 31AD) (Covid-19) \n(Operation of certain indoor premises) Regulations (S.I. No. 385 of 2021) are \namended – \n\n(a) \n\n(b) \n\nin Regulation 1(2), by the substitution of “9th day of January \n2022” for “9th day of November 2021”, and \n\nin Regulation 5(3), by the substitution of the following \ndefinition for the definition of “vaccinated person”: \n\n“‘vaccinated person’ means – \n\n(a) \n\nin relation to a person to whom the medicinal \nproduct for active immunisation to prevent \nCovid-19 known as ‘Spikevax (previously \nCOVID-19 Vaccine Moderna) CX-024414’ \nhas been administered, that person not less \nthan 14 days after the second dose of the \nconcerned has been \nmedicinal product \nadministered to him or her, \n\nNotice of the making of this Statutory Instrument was published in \n“Iris Oifigiúil” of 12th November, 2021. \n\n \n \n \n \n \n \n \n\f(b) \n\n(c) \n\n(d) \n\n(e) \n\n(f) \n\n(g) \n\n[586] 3 \n\nin relation to a person to whom the medicinal \nproduct for active immunisation to prevent \nCovid-19 known as ‘Vaxzevria (previously \nCOVID-19 Vaccine AstraZeneca) ChAdOx1SARS-COV-2’, also known as ‘Covishield’, \nhas been administered, that person not less \nthan 15 days after the second dose of the \nconcerned has been \nmedicinal product \nadministered to him or her, \n\nin relation to a person to whom the medicinal \nproduct authorised for active immunisation to \nprevent Covid-19 known as \n‘Comirnaty \nBNT162b2’ has been administered, that person \nnot less than 7 days after the second dose of \nthe medicinal product concerned has been \nadministered to him or her, \n\nin relation to a person to whom the medicinal \nproduct authorised for active immunisation to \n‘COVID-19 \nprevent Covid-19 known as \nVaccine \n(Ad26.COV2-S \n[recombinant])’ has been administered , that \nthe \nperson not \nmedicinal product \nconcerned has been \nadministered to him or her, \n\nthan 14 days after \n\nJanssen \n\nless \n\nin relation to a person to whom the medicinal \nproduct for active immunisation to prevent \nCovid-19 known as ‘COVID-19 Vaccine \n(Vero Cell) Inactivated’, also known as \nthat \n‘CoronaVac’, has been administered, \nperson not less than 14 days after the second \ndose of the medicinal product concerned has \nbeen administered to him or her, \n\nin relation to a person to whom the medicinal \nproduct for active immunisation to prevent \nCovid-19 known as ‘Inactivated COVID-19 \n(VERO CELL) vaccine’, also known as \n‘SinoPharm / BIBP’ has been administered, \nthat person not less than 14 days after the \nthe medicinal product \nsecond dose of \nconcerned has been administered to him or \nher, or \n\nrelation \n\nto a person \n\nto whom any \nin \ncombination of the medicinal products referred \nto in paragraphs (a), (b), (c), (e) and (f) has \nbeen administered - \n\n(i) \n\nin the case of the second dose being the \nin \nmedicinal product \n\nreferred \n\nto \n\n \n\f4 [586] \n\nparagraph (a), that person not less than \n14 days after the second dose of the \nmedicinal product concerned has been \nadministered to him or her, \n\n(ii) \n\n(iii) \n\n(iv) \n\n(v) \n\nreferred \n\nin the case of the second dose being the \nmedicinal product \nin \nparagraph (b), that person not less than \n15 days after the second dose of the \nmedicinal product concerned has been \nadministered to him or her, \n\nto \n\nreferred \n\nin the case of the second dose being the \nmedicinal product \nin \nparagraph (c), that person not less than 7 \ndays after \nthe \nmedicinal product concerned has been \nadministered to him or her, \n\nthe second dose of \n\nto \n\nreferred \n\nin the case of the second dose being the \nin \nmedicinal product \nparagraph (e), that person, not less than \n14 days after the second dose of the \nmedicinal product concerned has been \nadministered to him or her, or \n\nto \n\nreferred \n\nin the case of the second dose being the \nmedicinal product \nin \nparagraph (f), that person not less than \n14 days after the second dose of the \nmedicinal product concerned has been \nadministered to him or her .”. \n\nto \n\nGIVEN under my Official Seal, \n\n9 November, 2021. \n\nSTEPHEN DONNELLY, \nMinister for Health. \n\n \n \n \n \n \n \n \n \n \n\f[586] 5", "text_norm": "2 health act 1947 (sections 31ab 31ad) (covid-19) (operation certain indoor premises) regulation (s.i no 385 2021) amended - (a) (b) regulation 1(2) substitution 9th day january 2022 9th day november 2021 regulation 5(3) substitution following definition definition vaccinated person vaccinated person mean - (a) relation person medicinal product active immunisation prevent covid-19 known spikevax (previously covid-19 vaccine moderna) cx-024414 administered person le 14 day second dose concerned medicinal product administered notice making statutory instrument published iris oifigiuil 12th november 2021 (b) (c) (d) (e) (f) (g) 586 3 relation person medicinal product active immunisation prevent covid-19 known vaxzevria (previously covid-19 vaccine astrazeneca) chadox1sars-cov-2 also known covishield administered person le 15 day second dose concerned medicinal product administered relation person medicinal product authorised active immunisation prevent covid-19 known comirnaty bnt162b2 administered person le 7 day second dose medicinal product concerned administered relation person medicinal product authorised active immunisation covid-19 prevent covid-19 known vaccine (ad26.cov2-s recombinant ) administered person medicinal product concerned administered 14 day janssen le relation person medicinal product active immunisation prevent covid-19 known covid-19 vaccine (vero cell) inactivated also known coronavac administered person le 14 day second dose medicinal product concerned administered relation person medicinal product active immunisation prevent covid-19 known inactivated covid-19 (vero cell) vaccine also known sinopharm bibp administered person le 14 day medicinal product second dose concerned administered relation person combination medicinal product referred paragraph (a) (b) (c) (e) (f) administered - (i) case second dose medicinal product referred 4 586 paragraph (a) person le 14 day second dose medicinal product concerned administered (ii) (iii) (iv) (v) referred case second dose medicinal product paragraph (b) person le 15 day second dose medicinal product concerned administered referred case second dose medicinal product paragraph (c) person le 7 day medicinal product concerned administered second dose referred case second dose medicinal product paragraph (e) person le 14 day second dose medicinal product concerned administered referred case second dose medicinal product paragraph (f) person le 14 day second dose medicinal product concerned administered   given official seal 9 november 2021 stephen donnelly minister health 586 5", "start_char": 1375, "end_char": 5462, "source_path": "downloads\\2021\\2021_0586.pdf", "extraction_method": "pdfminer", "checksum": "sha256:2b49bf20f4fc1db37f539c4e692fdafbefe8a91a9fb1896b3cfd8bbcce9ce426", "cross_refs": []}
{"doc_id": "si-2021-0586-explanatory-note", "parent_doc_id": "si-2021-0586", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 586 of 2021", "title": "the Health (Amendment) (No. 2) Act 2021 (No. 24 of 2021)) of the Health Act", "year": 2021, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nHealth Act 1947 (Sections 31AB and 31AD) (Covid-19) (Operation of \ncertain indoor premises) (Amendment) (No. 8) Regulations 2021 \n\nThese regulations extend the operation of S.I 385 of 2021 (Operation of certain \nindoor premises) to provide for the acceptance of heterologous vaccination \ncourses and to extend the list of accepted vaccines to include vaccines from the \nWHO Emergency Use Listing (CoronaVac’ and ‘SinoPharm BIBP’). They \nextend the date of operation to 9th January. \n\n \n \n \n \n \n\f6 [586] \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \nBÓTHAR BHAILE UÍ BHEOLÁIN, \nCILL MHAIGHNEANN, \nBAILE ÁTHA CLIATH 8, \nD08 XAO6 \n\nTeil: 046 942 3100 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \nMOUNTSHANNON ROAD, \nKILMAINHAM, DUBLIN 8, \nD08 XAO6 \n\nTel: 046 942 3100 \nE-mail: publications@opw.ie \n—————— \n\n€ 3.00 \n\n(DH-327) 75. 11/21. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) health act 1947 (sections 31ab 31ad) (covid-19) (operation certain indoor premises) (amendment) (no 8) regulation 2021 regulation extend operation s.i 385 2021 (operation certain indoor premises) provide acceptance heterologous vaccination course extend list accepted vaccine include vaccine emergency use listing (coronavac sinopharm bibp ) extend date operation 9th january 6 586 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais bothar bhaile ui bheolain cill mhaighneann baile atha cliath 8 d08 xao6 teil 046 942 3100 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication mountshannon road kilmainham dublin 8 d08 xao6 tel 046 942 3100 e-mail publication opw.ie ------------ eur 3.00 (dh-327) 75 11 21 propylon", "start_char": 5462, "end_char": 6566, "source_path": "downloads\\2021\\2021_0586.pdf", "extraction_method": "pdfminer", "checksum": "sha256:2b49bf20f4fc1db37f539c4e692fdafbefe8a91a9fb1896b3cfd8bbcce9ce426", "cross_refs": []}
